146 related articles for article (PubMed ID: 2863324)
1. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
Rupniak NM; Hall MD; Kelly E; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
J Neural Transm; 1985; 62(3-4):249-66. PubMed ID: 2863324
[TBL] [Abstract][Full Text] [Related]
2. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
3. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
5. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study.
Moghaddam B; Bunney BS
J Neurochem; 1990 May; 54(5):1755-60. PubMed ID: 1969939
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
[TBL] [Abstract][Full Text] [Related]
9. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
Halperin R; Guerin JJ; Davis KL
Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
[TBL] [Abstract][Full Text] [Related]
10. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum.
de Belleroche JS; Neal MJ
Neuropharmacology; 1982 Jun; 21(6):529-37. PubMed ID: 6125910
[TBL] [Abstract][Full Text] [Related]
11. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
[TBL] [Abstract][Full Text] [Related]
12. The nucleus accumbens and antidepressants: modulation of ergometrine-induced hyperactivity by typical and atypical antidepressants and neuroleptics in rats.
Cools AR
Psychopharmacology (Berl); 1987; 92(3):350-7. PubMed ID: 2888148
[TBL] [Abstract][Full Text] [Related]
13. Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine.
Rupniak NM; Briggs RS; Petersen MM; Mann S; Reavill C; Jenner P; Marsden CD
Clin Neuropharmacol; 1986; 9(3):282-92. PubMed ID: 3719573
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
15. Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine.
Rupniak NM; Prestwich SA; Horton RW; Jenner P; Marsden CD
J Neural Transm; 1987; 68(1-2):113-25. PubMed ID: 3806083
[TBL] [Abstract][Full Text] [Related]
16. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
[TBL] [Abstract][Full Text] [Related]
17. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
[TBL] [Abstract][Full Text] [Related]
18. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
Prosser ES; Pruthi R; Csernansky JG
Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
[TBL] [Abstract][Full Text] [Related]
19. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
Kudrin VS; Hetey L; Morgenshtern R; Raevskiĭ KS; Olssner W
Farmakol Toksikol; 1987; 50(2):16-20. PubMed ID: 2884129
[TBL] [Abstract][Full Text] [Related]
20. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
